39
Growth Score
pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
977271
Dermelix focus is urgent because the need is great.
Nick France: Founder & CEO
About the Company
Dermelix is a clinical-stage biopharmaceutical company focused on delivering innovative treatments to patients suffering from rare genetic skin diseases. Our team consists of a small group of drug developers with extensive experience in getting drugs approved in the rare disease space. We are currently developing therapies across multiple
innovative therapeutic modalities.
